Stocks and Investing Stocks and Investing
Wed, November 15, 2023

Kristen Kluska Maintained (TSHA) at Buy with Increased Target to $7 on, Nov 15th, 2023


Published on 2024-10-28 07:35:52 - WOPRAI, Kristen Kluska
  Print publication without navigation


Kristen Kluska of Cantor Fitzgerald, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Increased Target from $6 to $7 on, Nov 15th, 2023.

Kristen has made no other calls on TSHA in the last 4 months.



There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 0 agree with Kristen's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Kristen


  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $5 on, Wednesday, September 20th, 2023
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $5 on, Wednesday, September 20th, 2023
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, September 20th, 2023
  • Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Tuesday, August 15th, 2023
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Tuesday, August 15th, 2023
  • Jack Allen of "Baird" Maintained at Buy with Increased Target to $8 on, Tuesday, August 15th, 2023
Contributing Sources